#METABOLOMICS WORKBENCH schrodm_20230112_095057 DATATRACK_ID:3687 STUDY_ID:ST002440 ANALYSIS_ID:AN003977 PROJECT_ID:PR001572
VERSION             	1
CREATED_ON             	January 13, 2023, 7:27 am
#PROJECT
PR:PROJECT_TITLE                 	Impacts of interactions between environmental chemical exposures and diet on gut
PR:PROJECT_TITLE                 	microbiota and microbiota-derived metabolites in mothers and children
PR:PROJECT_TYPE                  	C18 Reversed-Phase Broad Spectrum Metabolomics
PR:PROJECT_SUMMARY               	This project is funded by the NIH Environmental influences on Child Health
PR:PROJECT_SUMMARY               	Outcomes (ECHO) OIF program, and uses data from two cohorts: MAAP and MARCH.
PR:PROJECT_SUMMARY               	This project will examine associations with PFAS exposures and gut microbiota
PR:PROJECT_SUMMARY               	form and function in mothers and children over time. Untargeted metabolomics
PR:PROJECT_SUMMARY               	will be used as a means to assess changes in microbiota-derived metabolites.
PR:INSTITUTE                     	NC HHEAR Hub
PR:DEPARTMENT                    	Untargeted Analysis
PR:LABORATORY                    	Sumner Lab
PR:LAST_NAME                     	Li
PR:FIRST_NAME                    	Yuanyuan
PR:ADDRESS                       	Nutrition Research Institute, UNC-CH, 500 Laureate Way, Kannapolis, NC 28081
PR:EMAIL                         	yuanyli4@unc.edu
PR:PHONE                         	984-377-0693
PR:FUNDING_SOURCE                	This research was supported by the Environmental influences on Child Health
PR:FUNDING_SOURCE                	Outcomes (ECHO) OIF program, Office of The Director, National Institutes of
PR:FUNDING_SOURCE                	Health. The content is solely the responsibility of the authors and does not
PR:FUNDING_SOURCE                	necessarily represent the official views of the National Institutes of Health.
PR:FUNDING_SOURCE                	MAAP is an ECHO cohort which is supported by the following ECHO Program
PR:FUNDING_SOURCE                	Collaborators: ECHO Coordinating Center: Duke Clinical Research Institute,
PR:FUNDING_SOURCE                	Durham, North Carolina: Smith PB, Newby KL, Benjamin DK; U2C OD023375; ECHO Data
PR:FUNDING_SOURCE                	Analysis Center: Johns Hopkins University Bloomberg School of Public Health,
PR:FUNDING_SOURCE                	Baltimore, Maryland: Jacobson LP; Research Triangle Institute, Durham, North
PR:FUNDING_SOURCE                	Carolina: Catellier.D  U24 OD023382; North Carolina Human Health Exposure
PR:FUNDING_SOURCE                	Analysis Resource Hub: Research Triangle Institute: Fennell T, University of
PR:FUNDING_SOURCE                	North Carolina at Chapel Hill: Sumner S, University of North Carolina at
PR:FUNDING_SOURCE                	Charlotte: Du X; U2C ES030857; Human Health Exposure Analysis Resource
PR:FUNDING_SOURCE                	Coordinating Center: Westat, Inc., Rockville, Maryland: O’Brien B; U24
PR:FUNDING_SOURCE                	ES026539
#STUDY
ST:STUDY_TITLE                   	Impacts of interactions between environmental chemical exposures and diet on gut
ST:STUDY_TITLE                   	microbiota and microbiota-derived metabolites in mothers and children (MAAP
ST:STUDY_TITLE                   	Cohort)
ST:STUDY_TYPE                    	Prospective Cohort Study
ST:STUDY_SUMMARY                 	In 2014, the Microbes, Allergy, Asthma and Pets (MAAP) study (P01 AI089473) was
ST:STUDY_SUMMARY                 	launched. All women ages 18-49 years scheduled for prenatal visits at Henry Ford
ST:STUDY_SUMMARY                 	Health, expected to deliver during the recruitment period at a Henry Ford Health
ST:STUDY_SUMMARY                 	hospital, and whose residence was in a predefined area of Detroit and
ST:STUDY_SUMMARY                 	metropolitan Detroit suburbs were potentially eligible. There were no medical
ST:STUDY_SUMMARY                 	insurance requirements. Between 2014 and 2016, 141 women were enrolled; their
ST:STUDY_SUMMARY                 	infant was followed through age 18 months (with continuing follow-up through
ST:STUDY_SUMMARY                 	early/mid childhood underway through the NIH ECHO program under the CREW birth
ST:STUDY_SUMMARY                 	cohort consortium (5UG3OD023282, Gern PI). Blood and stool samples were obtained
ST:STUDY_SUMMARY                 	from the mother prenatally and stool specimens were obtained from the infant at
ST:STUDY_SUMMARY                 	5 time points (1-week, 1-, 3-, 6- and 18-months) with 16S sequencing already
ST:STUDY_SUMMARY                 	completed. Blood was also obtained from the infant at pre-defined intervals.
ST:STUDY_SUMMARY                 	Please contact Andrea Cassidy-Bushrow at acassid1@hfhs.org for questions related
ST:STUDY_SUMMARY                 	to the subject characteristics and outcomes. This research was supported by the
ST:STUDY_SUMMARY                 	Environmental influences on Child Health Outcomes (ECHO) OIF program, Office of
ST:STUDY_SUMMARY                 	The Director, National Institutes of Health. The content is solely the
ST:STUDY_SUMMARY                 	responsibility of the authors and does not necessarily represent the official
ST:STUDY_SUMMARY                 	views of the National Institutes of Health. MAAP is an ECHO cohort which is
ST:STUDY_SUMMARY                 	supported by the following ECHO Program Collaborators: ECHO Coordinating Center:
ST:STUDY_SUMMARY                 	Duke Clinical Research Institute, Durham, North Carolina: Smith PB, Newby KL,
ST:STUDY_SUMMARY                 	Benjamin DK; U2C OD023375 ECHO Data Analysis Center: Johns Hopkins University
ST:STUDY_SUMMARY                 	Bloomberg School of Public Health, Baltimore, Maryland: Jacobson LP; Research
ST:STUDY_SUMMARY                 	Triangle Institute, Durham, North Carolina: Catellier.D  U24 OD023382 North
ST:STUDY_SUMMARY                 	Carolina Human Health Exposure Analysis Resource Hub: Research Triangle
ST:STUDY_SUMMARY                 	Institute: Fennell T, University of North Carolina at Chapel Hill: Sumner S,
ST:STUDY_SUMMARY                 	University of North Carolina at Charlotte: Du X; U2C ES030857 Human Health
ST:STUDY_SUMMARY                 	Exposure Analysis Resource Coordinating Center: Westat, Inc., Rockville,
ST:STUDY_SUMMARY                 	Maryland: O’Brien B; U24 ES026539
ST:INSTITUTE                     	Wayne State University
ST:DEPARTMENT                    	Pharmacology
ST:LAST_NAME                     	Petriello
ST:FIRST_NAME                    	Michael
ST:ADDRESS                       	6135 Woodward Ave, Detroit, MI 48202
ST:EMAIL                         	michael.petriello@wayne.edu
ST:PHONE                         	313-577-1089
ST:TOTAL_SUBJECTS                	31
ST:STUDY_COMMENTS                	ECHO Project EC0549, HHEAR Project E020-0012
#SUBJECT
SU:SUBJECT_TYPE                  	Human
SU:SUBJECT_SPECIES               	Homo sapiens
SU:TAXONOMY_ID                   	9606
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	N/A	MAAP_HHEAR_1	Sample Type:HHEAR Pool	RAW_FILE_NAME=MAAP_HHEAR_1
SUBJECT_SAMPLE_FACTORS           	N/A	MAAP_HHEAR_2	Sample Type:HHEAR Pool	RAW_FILE_NAME=MAAP_HHEAR_2
SUBJECT_SAMPLE_FACTORS           	N/A	MAAP_HHEAR_3	Sample Type:HHEAR Pool	RAW_FILE_NAME=MAAP_HHEAR_3
SUBJECT_SAMPLE_FACTORS           	N/A	MAAP_HHEAR_4	Sample Type:HHEAR Pool	RAW_FILE_NAME=MAAP_HHEAR_4
SUBJECT_SAMPLE_FACTORS           	N/A	MAAP_NIST_1	Sample Type:NIST Pool	RAW_FILE_NAME=MAAP_NIST_1
SUBJECT_SAMPLE_FACTORS           	N/A	MAAP_NIST_2	Sample Type:NIST Pool	RAW_FILE_NAME=MAAP_NIST_2
SUBJECT_SAMPLE_FACTORS           	N/A	MAAP_NIST_3	Sample Type:NIST Pool	RAW_FILE_NAME=MAAP_NIST_3
SUBJECT_SAMPLE_FACTORS           	N/A	MAAP_NIST_4	Sample Type:NIST Pool	RAW_FILE_NAME=MAAP_NIST_4
SUBJECT_SAMPLE_FACTORS           	EO-7NXJ0-P-00-11302	MAAP_S_1	Sample Type:Study Sample	RAW_FILE_NAME=MAAP_S_1
SUBJECT_SAMPLE_FACTORS           	EO-7N015-P-00-11302	MAAP_S_2	Sample Type:Study Sample	RAW_FILE_NAME=MAAP_S_2
SUBJECT_SAMPLE_FACTORS           	EO-7NVJ2-P-00-11302	MAAP_S_3	Sample Type:Study Sample	RAW_FILE_NAME=MAAP_S_3
SUBJECT_SAMPLE_FACTORS           	EO-7NR03-P-00-11302	MAAP_S_4	Sample Type:Study Sample	RAW_FILE_NAME=MAAP_S_4
SUBJECT_SAMPLE_FACTORS           	EO-7N4A6-P-00-11302	MAAP_S_5	Sample Type:Study Sample	RAW_FILE_NAME=MAAP_S_5
SUBJECT_SAMPLE_FACTORS           	EO-7P2K2-P-00-11302	MAAP_S_6	Sample Type:Study Sample	RAW_FILE_NAME=MAAP_S_6
SUBJECT_SAMPLE_FACTORS           	EO-7N528-P-00-11302	MAAP_S_7	Sample Type:Study Sample	RAW_FILE_NAME=MAAP_S_7
SUBJECT_SAMPLE_FACTORS           	EO-7N981-P-00-11302	MAAP_S_8	Sample Type:Study Sample	RAW_FILE_NAME=MAAP_S_8
SUBJECT_SAMPLE_FACTORS           	EO-7NKQ8-P-00-11302	MAAP_S_9	Sample Type:Study Sample	RAW_FILE_NAME=MAAP_S_9
SUBJECT_SAMPLE_FACTORS           	EO-7NHF5-P-00-11302	MAAP_S_10	Sample Type:Study Sample	RAW_FILE_NAME=MAAP_S_10
SUBJECT_SAMPLE_FACTORS           	EO-7NMG8-P-00-11302	MAAP_S_11	Sample Type:Study Sample	RAW_FILE_NAME=MAAP_S_11
SUBJECT_SAMPLE_FACTORS           	EO-7N1M3-P-00-11302	MAAP_S_12	Sample Type:Study Sample	RAW_FILE_NAME=MAAP_S_12
SUBJECT_SAMPLE_FACTORS           	EO-7N353-P-00-11302	MAAP_S_13	Sample Type:Study Sample	RAW_FILE_NAME=MAAP_S_13
SUBJECT_SAMPLE_FACTORS           	EO-7N841-P-00-11302	MAAP_S_14	Sample Type:Study Sample	RAW_FILE_NAME=MAAP_S_14
SUBJECT_SAMPLE_FACTORS           	EO-7NZ54-P-00-11302	MAAP_S_15	Sample Type:Study Sample	RAW_FILE_NAME=MAAP_S_15
SUBJECT_SAMPLE_FACTORS           	EO-7NQ53-P-00-11302	MAAP_S_16	Sample Type:Study Sample	RAW_FILE_NAME=MAAP_S_16
SUBJECT_SAMPLE_FACTORS           	EO-7NJ92-P-00-11302	MAAP_S_17	Sample Type:Study Sample	RAW_FILE_NAME=MAAP_S_17
SUBJECT_SAMPLE_FACTORS           	EO-7NKK1-P-00-11302	MAAP_S_18	Sample Type:Study Sample	RAW_FILE_NAME=MAAP_S_18
SUBJECT_SAMPLE_FACTORS           	EO-7NR94-P-00-11302	MAAP_S_19	Sample Type:Study Sample	RAW_FILE_NAME=MAAP_S_19
SUBJECT_SAMPLE_FACTORS           	EO-7N2H3-P-00-11302	MAAP_S_20	Sample Type:Study Sample	RAW_FILE_NAME=MAAP_S_20
SUBJECT_SAMPLE_FACTORS           	EO-7NXP7-P-00-11302	MAAP_S_21	Sample Type:Study Sample	RAW_FILE_NAME=MAAP_S_21
SUBJECT_SAMPLE_FACTORS           	EO-7N338-P-00-11302	MAAP_S_22	Sample Type:Study Sample	RAW_FILE_NAME=MAAP_S_22
SUBJECT_SAMPLE_FACTORS           	EO-7NL33-P-00-11302	MAAP_S_23	Sample Type:Study Sample	RAW_FILE_NAME=MAAP_S_23
SUBJECT_SAMPLE_FACTORS           	EO-7NGG4-P-00-11302	MAAP_S_24	Sample Type:Study Sample	RAW_FILE_NAME=MAAP_S_24
SUBJECT_SAMPLE_FACTORS           	EO-7N2C4-P-00-11302	MAAP_S_25	Sample Type:Study Sample	RAW_FILE_NAME=MAAP_S_25
SUBJECT_SAMPLE_FACTORS           	EO-7NR29-P-00-11302	MAAP_S_26	Sample Type:Study Sample	RAW_FILE_NAME=MAAP_S_26
SUBJECT_SAMPLE_FACTORS           	EO-7NW08-P-00-11302	MAAP_S_27	Sample Type:Study Sample	RAW_FILE_NAME=MAAP_S_27
SUBJECT_SAMPLE_FACTORS           	EO-7P0D9-P-00-11302	MAAP_S_28	Sample Type:Study Sample	RAW_FILE_NAME=MAAP_S_28
SUBJECT_SAMPLE_FACTORS           	EO-7NYH4-P-00-11302	MAAP_S_29	Sample Type:Study Sample	RAW_FILE_NAME=MAAP_S_29
SUBJECT_SAMPLE_FACTORS           	EO-7NR11-P-00-11302	MAAP_S_30	Sample Type:Study Sample	RAW_FILE_NAME=MAAP_S_30
SUBJECT_SAMPLE_FACTORS           	EO-7P2Q9-P-00-11302	MAAP_S_31	Sample Type:Study Sample	RAW_FILE_NAME=MAAP_S_31
SUBJECT_SAMPLE_FACTORS           	N/A	MAAP_SP_1	Sample Type:Study Pool	RAW_FILE_NAME=MAAP_SP_1
SUBJECT_SAMPLE_FACTORS           	N/A	MAAP_SP_2	Sample Type:Study Pool	RAW_FILE_NAME=MAAP_SP_2
SUBJECT_SAMPLE_FACTORS           	N/A	MAAP_SP_3	Sample Type:Study Pool	RAW_FILE_NAME=MAAP_SP_3
SUBJECT_SAMPLE_FACTORS           	N/A	MAAP_SP_4	Sample Type:Study Pool	RAW_FILE_NAME=MAAP_SP_4
#COLLECTION
CO:COLLECTION_SUMMARY            	In 2014, the Microbes, Allergy, Asthma and Pets (MAAP) study (P01 AI089473) was
CO:COLLECTION_SUMMARY            	launched. All women ages 18-49 years scheduled for prenatal visits at Henry Ford
CO:COLLECTION_SUMMARY            	Health, expected to deliver during the recruitment period at a Henry Ford Health
CO:COLLECTION_SUMMARY            	hospital, and whose residence was in a predefined area of Detroit and
CO:COLLECTION_SUMMARY            	metropolitan Detroit suburbs were potentially eligible. There were no medical
CO:COLLECTION_SUMMARY            	insurance requirements. Between 2014 and 2016, 141 women were enrolled; their
CO:COLLECTION_SUMMARY            	infant was followed through age 18 months (with continuing follow-up through
CO:COLLECTION_SUMMARY            	early/mid childhood underway through the NIH ECHO program under the CREW birth
CO:COLLECTION_SUMMARY            	cohort consortium (5UG3OD023282, Gern PI). Blood and stool samples were obtained
CO:COLLECTION_SUMMARY            	from the mother prenatally and stool specimens were obtained from the infant at
CO:COLLECTION_SUMMARY            	5 time points (1-week, 1-, 3-, 6- and 18-months) with 16S sequencing already
CO:COLLECTION_SUMMARY            	completed. Blood was also obtained from the infant at pre-defined intervals.
CO:COLLECTION_SUMMARY            	Please contact Andrea Cassidy-Bushrow at acassid1@hfhs.org for questions related
CO:COLLECTION_SUMMARY            	to the subject characteristics and outcomes.
CO:SAMPLE_TYPE                   	Blood (plasma)
CO:STORAGE_CONDITIONS            	-80℃
#TREATMENT
TR:TREATMENT_SUMMARY             	N/A
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	Study samples (500-1000 µL aliquots) were shipped from the Henry Ford Health
SP:SAMPLEPREP_SUMMARY            	System to the NC HHEAR Hub on dry ice. The NC HHEAR Hub thawed and aliquoted the
SP:SAMPLEPREP_SUMMARY            	study samples at 50 µL per aliquot. An additional 10 µL was taken from each
SP:SAMPLEPREP_SUMMARY            	study sample, mixed, and distributed at 50 µL per aliquot, which were used as
SP:SAMPLEPREP_SUMMARY            	QC study pools throughout the study. HHEAR reference plasma (50 µL each) and
SP:SAMPLEPREP_SUMMARY            	NIST plasma (1950) reference material (50 µL each) were provided by the NC
SP:SAMPLEPREP_SUMMARY            	HHEAR Hub. LC-MS grade water (50 µL) was used as blank. All samples were thawed
SP:SAMPLEPREP_SUMMARY            	at 4°C overnight before the preparation. Samples, including study samples,
SP:SAMPLEPREP_SUMMARY            	study pool samples, HHEAR reference plasma, NIST reference plasma, and blanks
SP:SAMPLEPREP_SUMMARY            	were mixed with 400 µL methanol containing 500 ng/mL tryptophan-d5 as internal
SP:SAMPLEPREP_SUMMARY            	standard and vortexed by a multiple tube vortex mixer for 2 min at 5000 rpm at
SP:SAMPLEPREP_SUMMARY            	room temperature. All samples were centrifuged at 16,000 rcf for 10 min at 4°C.
SP:SAMPLEPREP_SUMMARY            	The supernatant (350 µL) was transferred into a pre-labeled 2.0 mL Lo-bind
SP:SAMPLEPREP_SUMMARY            	Eppendorf tube, dried by a SpeedVac overnight, and stored at -80° C. For
SP:SAMPLEPREP_SUMMARY            	immediate analysis, 100 µL of water-methanol solution (95:5, v/v) was used to
SP:SAMPLEPREP_SUMMARY            	reconstitute the dried extracts. Samples were thoroughly mixed on a multiple
SP:SAMPLEPREP_SUMMARY            	tube vortex mixer for 10 min at 5000 rpm at room temperature and then
SP:SAMPLEPREP_SUMMARY            	centrifuged at 4°C for 10 min at 16,000 rcf. The supernatant was transferred to
SP:SAMPLEPREP_SUMMARY            	pre-labeled autosampler vials for data acquisition by LC-MS.
SP:PROCESSING_STORAGE_CONDITIONS 	On ice
SP:EXTRACTION_METHOD             	Vortex with methanol containing 500ng/ml tryptophan-d5 as internal standard
SP:EXTRACT_STORAGE               	-80℃
SP:SAMPLE_RESUSPENSION           	Water-Methanol (95:5, v/v)
SP:SAMPLE_SPIKING                	Tryptophan-d5 stock solution at 500 ng/mL
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_TYPE           	Reversed phase
CH:INSTRUMENT_NAME               	Thermo Vanquish
CH:COLUMN_NAME                   	Waters ACQUITY UPLC HSS T3 (100 x 2.1mm,1.8um)
CH:SOLVENT_A                     	100% water; 0.1% formic acid
CH:SOLVENT_B                     	100% methanol; 0.1% formic acid
CH:FLOW_GRADIENT                 	Time(min) Flow Rate %A %B Curve 1. 0 0.4 99.0 1.0 5 2. 1.00 0.4 99.0 1.0 5 3.
CH:FLOW_GRADIENT                 	16.00 0.4 1.0 99.0 5 4. 19.00 0.4 1.0 99.0 5 5. 19.50 0.4 99.0 1.0 5 6. 22.00
CH:FLOW_GRADIENT                 	0.4 99.0 1.0 5
CH:FLOW_RATE                     	0.4 mL/min
CH:COLUMN_TEMPERATURE            	50
CH:COLUMN_PRESSURE               	6000-10000 psi
CH:INJECTION_TEMPERATURE         	8
CH:INTERNAL_STANDARD             	Tryptophan-d5
CH:ANALYTICAL_TIME               	22 min
CH:WEAK_WASH_SOLVENT_NAME        	10:90 Methanol:Water with 0.1% FA solution
CH:STRONG_WASH_SOLVENT_NAME      	75:25 2-Propanol:Water with 0.1% FA solution
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	Thermo Q Exactive HF-X Orbitrap
MS:INSTRUMENT_TYPE               	Orbitrap
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	POSITIVE
MS:MS_COMMENTS                   	Xcalibur 4.1.31.9 for data acquisition; Progenesis QI 2.4 for data preprocessing
MS:CAPILLARY_TEMPERATURE         	320 °C
MS:CAPILLARY_VOLTAGE             	3.5 kV
MS:COLLISION_ENERGY              	20-45, ramp
MS:COLLISION_GAS                 	N2
MS:DRY_GAS_TEMP                  	400°C
MS:FRAGMENTATION_METHOD          	CID
MS:DESOLVATION_GAS_FLOW          	55
MS:MS_RESULTS_FILE               	ST002440_AN003977_Results.txt	UNITS:Peak area	Has m/z:Yes	Has RT:Yes	RT units:Minutes
#END